Perioperative immunosuppression as a critical determinant of early outcome after discordant xenoislet transplantation: a comparative study.
Troppmann
C
C
Department of Surgery, University of Minnesota Hospital, Minneapolis 55455, USA.
Papalois
B E
BE
Gruessner
A C
AC
Moon
C
C
Matas
A J
AJ
Sehgal
S N
SN
Nakhleh
R E
RE
Gruessner
R W
RW
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D016572:Cyclosporine / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000601:surgery; D004285:Dogs; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006085:Graft Survival / Q000187:drug effects*; D006146:Guanidines / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D011090:Polyenes / Q000627:therapeutic use; D051381:Rats; D011917:Rats, Inbred Lew; D020123:Sirolimus; D016559:Tacrolimus / Q000627:therapeutic use; D014183:Transplantation, Heterologous / Q000276:immunology / Q000473:pathology / Q000502:physiology*
D001786:Blood Glucose; D006146:Guanidines; D007166:Immunosuppressive Agents; D011090:Polyenes; D016572:Cyclosporine; C037258:gusperimus; D020123:Sirolimus; D016559:Tacrolimus